Procedural characteristics and post-procedural outcomes in the device group according to sex
| . | Overall (n = 556) . | Women (n = 316) . | Men (n = 240) . | P-value . |
|---|---|---|---|---|
| Procedure | ||||
| ȃDuration of procedure (min) | 132.2 ± 63.7 | 132.4 ± 66.4 | 132.0 ± 60.4 | 0.95 |
| ȃConcomitant mitral or aortic intervention | 127 (33.0) | 69 (30.3) | 58 (36.9) | 0.21 |
| Type of TTVI | – | – | – | <0.01 |
| ȃTEER | 435 (78.2) | 235 (74.4) | 200 (83.3) | – |
| TTVR | 13 (2.3) | 11 (3.5) | 2 (0.8) | – |
| ȃAnnuloplasty | 52 (9.4) | 40 (12.7) | 12 (5.0) | – |
| Others | 56 (10.1) | 30 (9.5) | 26 (10.8) | – |
| Number of clips | – | – | – | <0.01 |
| 1 | 20 (4.7) | 8 (3.4) | 12 (6.2) | – |
| ȃ2 | 105 (24.6) | 67 (28.9) | 38 (19.6) | – |
| 3 | 199 (46.7) | 115 (49.6) | 84 (43.3) | – |
| ȃ4 | 87 (20.4) | 39 (16.8) | 48 (24.7) | – |
| 5 | 13 (3.1) | 3 (1.3) | 10 (5.2) | – |
| ȃ6 | 2 (0.5) | 0 (0.0) | 2 (1.0) | – |
| Post-procedure outcomes | ||||
| ȃProcedural success | 415 (78.4) | 237 (79.5) | 178 (77.1) | 0.56 |
| AKI | 51 (12.4) | 26 (10.8) | 25 (14.6) | 0.32 |
| ȃNew-onset atrial fibrillation | 6 (1.4) | 5 (2.1) | 1 (0.6) | 0.41 |
| Stroke | 4 (0.9) | 3 (1.2) | 1 (0.5) | 0.64 |
| ȃLength of stay (days) | 4 (2–7) | 4 (2–7) | 4 (3–7) | 0.59 |
| Conversion to surgery | 7 (1.6) | 3 (1.2) | 4 (2.1) | 0.46 |
| ȃIn-hospital death | 13 (2.9) | 9 (3.5) | 4 (2.1) | 0.57 |
| 30-day outcomes | ||||
| ȃTAPSE (mm) | 15.7 ± 4.5 | 15.6 ± 4.5 | 15.8 ± 4.7 | 0.79 |
| SPAP (mmHg) | 43.3 ± 14.8 | 44.2 ± 14.1 | 41.9 ± 15.8 | 0.22 |
| ȃAll-cause mortality | 20 (4.9) | 11 (4.5) | 9 (5.6) | 0.82 |
| . | Overall (n = 556) . | Women (n = 316) . | Men (n = 240) . | P-value . |
|---|---|---|---|---|
| Procedure | ||||
| ȃDuration of procedure (min) | 132.2 ± 63.7 | 132.4 ± 66.4 | 132.0 ± 60.4 | 0.95 |
| ȃConcomitant mitral or aortic intervention | 127 (33.0) | 69 (30.3) | 58 (36.9) | 0.21 |
| Type of TTVI | – | – | – | <0.01 |
| ȃTEER | 435 (78.2) | 235 (74.4) | 200 (83.3) | – |
| TTVR | 13 (2.3) | 11 (3.5) | 2 (0.8) | – |
| ȃAnnuloplasty | 52 (9.4) | 40 (12.7) | 12 (5.0) | – |
| Others | 56 (10.1) | 30 (9.5) | 26 (10.8) | – |
| Number of clips | – | – | – | <0.01 |
| 1 | 20 (4.7) | 8 (3.4) | 12 (6.2) | – |
| ȃ2 | 105 (24.6) | 67 (28.9) | 38 (19.6) | – |
| 3 | 199 (46.7) | 115 (49.6) | 84 (43.3) | – |
| ȃ4 | 87 (20.4) | 39 (16.8) | 48 (24.7) | – |
| 5 | 13 (3.1) | 3 (1.3) | 10 (5.2) | – |
| ȃ6 | 2 (0.5) | 0 (0.0) | 2 (1.0) | – |
| Post-procedure outcomes | ||||
| ȃProcedural success | 415 (78.4) | 237 (79.5) | 178 (77.1) | 0.56 |
| AKI | 51 (12.4) | 26 (10.8) | 25 (14.6) | 0.32 |
| ȃNew-onset atrial fibrillation | 6 (1.4) | 5 (2.1) | 1 (0.6) | 0.41 |
| Stroke | 4 (0.9) | 3 (1.2) | 1 (0.5) | 0.64 |
| ȃLength of stay (days) | 4 (2–7) | 4 (2–7) | 4 (3–7) | 0.59 |
| Conversion to surgery | 7 (1.6) | 3 (1.2) | 4 (2.1) | 0.46 |
| ȃIn-hospital death | 13 (2.9) | 9 (3.5) | 4 (2.1) | 0.57 |
| 30-day outcomes | ||||
| ȃTAPSE (mm) | 15.7 ± 4.5 | 15.6 ± 4.5 | 15.8 ± 4.7 | 0.79 |
| SPAP (mmHg) | 43.3 ± 14.8 | 44.2 ± 14.1 | 41.9 ± 15.8 | 0.22 |
| ȃAll-cause mortality | 20 (4.9) | 11 (4.5) | 9 (5.6) | 0.82 |
Data are mean ± SD, median (interquartile range), or n (%).
AKI, acute kidney injury; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TEER, transcatheter edge-to-edge repair; TTVI, transcatheter tricuspid valve intervention; TTVR, transcatheter tricuspid valve replacement.
Procedural characteristics and post-procedural outcomes in the device group according to sex
| . | Overall (n = 556) . | Women (n = 316) . | Men (n = 240) . | P-value . |
|---|---|---|---|---|
| Procedure | ||||
| ȃDuration of procedure (min) | 132.2 ± 63.7 | 132.4 ± 66.4 | 132.0 ± 60.4 | 0.95 |
| ȃConcomitant mitral or aortic intervention | 127 (33.0) | 69 (30.3) | 58 (36.9) | 0.21 |
| Type of TTVI | – | – | – | <0.01 |
| ȃTEER | 435 (78.2) | 235 (74.4) | 200 (83.3) | – |
| TTVR | 13 (2.3) | 11 (3.5) | 2 (0.8) | – |
| ȃAnnuloplasty | 52 (9.4) | 40 (12.7) | 12 (5.0) | – |
| Others | 56 (10.1) | 30 (9.5) | 26 (10.8) | – |
| Number of clips | – | – | – | <0.01 |
| 1 | 20 (4.7) | 8 (3.4) | 12 (6.2) | – |
| ȃ2 | 105 (24.6) | 67 (28.9) | 38 (19.6) | – |
| 3 | 199 (46.7) | 115 (49.6) | 84 (43.3) | – |
| ȃ4 | 87 (20.4) | 39 (16.8) | 48 (24.7) | – |
| 5 | 13 (3.1) | 3 (1.3) | 10 (5.2) | – |
| ȃ6 | 2 (0.5) | 0 (0.0) | 2 (1.0) | – |
| Post-procedure outcomes | ||||
| ȃProcedural success | 415 (78.4) | 237 (79.5) | 178 (77.1) | 0.56 |
| AKI | 51 (12.4) | 26 (10.8) | 25 (14.6) | 0.32 |
| ȃNew-onset atrial fibrillation | 6 (1.4) | 5 (2.1) | 1 (0.6) | 0.41 |
| Stroke | 4 (0.9) | 3 (1.2) | 1 (0.5) | 0.64 |
| ȃLength of stay (days) | 4 (2–7) | 4 (2–7) | 4 (3–7) | 0.59 |
| Conversion to surgery | 7 (1.6) | 3 (1.2) | 4 (2.1) | 0.46 |
| ȃIn-hospital death | 13 (2.9) | 9 (3.5) | 4 (2.1) | 0.57 |
| 30-day outcomes | ||||
| ȃTAPSE (mm) | 15.7 ± 4.5 | 15.6 ± 4.5 | 15.8 ± 4.7 | 0.79 |
| SPAP (mmHg) | 43.3 ± 14.8 | 44.2 ± 14.1 | 41.9 ± 15.8 | 0.22 |
| ȃAll-cause mortality | 20 (4.9) | 11 (4.5) | 9 (5.6) | 0.82 |
| . | Overall (n = 556) . | Women (n = 316) . | Men (n = 240) . | P-value . |
|---|---|---|---|---|
| Procedure | ||||
| ȃDuration of procedure (min) | 132.2 ± 63.7 | 132.4 ± 66.4 | 132.0 ± 60.4 | 0.95 |
| ȃConcomitant mitral or aortic intervention | 127 (33.0) | 69 (30.3) | 58 (36.9) | 0.21 |
| Type of TTVI | – | – | – | <0.01 |
| ȃTEER | 435 (78.2) | 235 (74.4) | 200 (83.3) | – |
| TTVR | 13 (2.3) | 11 (3.5) | 2 (0.8) | – |
| ȃAnnuloplasty | 52 (9.4) | 40 (12.7) | 12 (5.0) | – |
| Others | 56 (10.1) | 30 (9.5) | 26 (10.8) | – |
| Number of clips | – | – | – | <0.01 |
| 1 | 20 (4.7) | 8 (3.4) | 12 (6.2) | – |
| ȃ2 | 105 (24.6) | 67 (28.9) | 38 (19.6) | – |
| 3 | 199 (46.7) | 115 (49.6) | 84 (43.3) | – |
| ȃ4 | 87 (20.4) | 39 (16.8) | 48 (24.7) | – |
| 5 | 13 (3.1) | 3 (1.3) | 10 (5.2) | – |
| ȃ6 | 2 (0.5) | 0 (0.0) | 2 (1.0) | – |
| Post-procedure outcomes | ||||
| ȃProcedural success | 415 (78.4) | 237 (79.5) | 178 (77.1) | 0.56 |
| AKI | 51 (12.4) | 26 (10.8) | 25 (14.6) | 0.32 |
| ȃNew-onset atrial fibrillation | 6 (1.4) | 5 (2.1) | 1 (0.6) | 0.41 |
| Stroke | 4 (0.9) | 3 (1.2) | 1 (0.5) | 0.64 |
| ȃLength of stay (days) | 4 (2–7) | 4 (2–7) | 4 (3–7) | 0.59 |
| Conversion to surgery | 7 (1.6) | 3 (1.2) | 4 (2.1) | 0.46 |
| ȃIn-hospital death | 13 (2.9) | 9 (3.5) | 4 (2.1) | 0.57 |
| 30-day outcomes | ||||
| ȃTAPSE (mm) | 15.7 ± 4.5 | 15.6 ± 4.5 | 15.8 ± 4.7 | 0.79 |
| SPAP (mmHg) | 43.3 ± 14.8 | 44.2 ± 14.1 | 41.9 ± 15.8 | 0.22 |
| ȃAll-cause mortality | 20 (4.9) | 11 (4.5) | 9 (5.6) | 0.82 |
Data are mean ± SD, median (interquartile range), or n (%).
AKI, acute kidney injury; SPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TEER, transcatheter edge-to-edge repair; TTVI, transcatheter tricuspid valve intervention; TTVR, transcatheter tricuspid valve replacement.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
